- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19
Authors
Keywords
-
Journal
JACC-Basic to Translational Science
Volume 6, Issue 12, Pages 935-945
Publisher
Elsevier BV
Online
2021-12-09
DOI
10.1016/j.jacbts.2021.09.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
- (2021) Annabelle Dupont et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Multiple Biomarker Approach to Risk Stratification in COVID-19
- (2021) Nathaniel R. Smilowitz et al. CIRCULATION
- Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience
- (2021) Clare Bryce et al. MODERN PATHOLOGY
- The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review
- (2021) Chiara Agrati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study
- (2021) Emre Karsli et al. LIFE SCIENCES
- COVID-19 and its implications for thrombosis and anticoagulation
- (2020) Jean Marie Connors et al. BLOOD
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID ‐19
- (2020) Hanny Al‐Samkari et al. AMERICAN JOURNAL OF HEMATOLOGY
- Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
- (2020) Paul C Evans et al. CARDIOVASCULAR RESEARCH
- Biomarkers of Platelet Activity and Vascular Health Associate with Thrombosis and Mortality in Patients with COVID-19
- (2020) Tessa J Barrett et al. CIRCULATION RESEARCH
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
- (2020) George Goshua et al. Lancet Haematology
- Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19
- (2020) Jeffrey S. Berger et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Severe COVID-19 is a Microvascular Disease
- (2020) Charles J. Lowenstein et al. CIRCULATION
- COVID-19 is, in the end, an endothelial disease
- (2020) Peter Libby et al. EUROPEAN HEART JOURNAL
- The coagulopathy, endotheliopathy, and vasculitis of COVID-19
- (2020) Toshiaki Iba et al. INFLAMMATION RESEARCH
- Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises
- (2019) Emilia A Barbu et al. CYTOKINE
- A Test in Context: D-Dimer
- (2017) Jeffrey I. Weitz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
- (2017) Kenneth I. Ataga et al. NEW ENGLAND JOURNAL OF MEDICINE
- P-selectin promotes neutrophil extracellular trap formation in mice
- (2015) J. Etulain et al. BLOOD
- Correlation between D-dimer levels and coronary artery reperfusion in acute myocardial infarction patients after thrombolytic treatment
- (2013) Mehmet A. Cakar et al. BLOOD COAGULATION & FIBRINOLYSIS
- D-dimer antigen: current concepts and future prospects
- (2008) S. S. Adam et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search